TriSalus Life Sciences Inc (TLSI)

Currency in USD
2.320
+0.145(+6.67%)
Closed·
2.3200.000(0.00%)
·

TLSI Financial Summary

Key Ratios

P/E Ratio-4.82
Price/Book208.56
Debt / Equity4,954.56%
Return on Equity201.61%
Dividend Yield0.00%
EBITDA-26.32M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
2025
31/12
* In Millions of USD (except for per share items)

Analyst Ratings

4 Buy
0 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 7.800
(+236.21% Upside)

Earnings

Latest Release
Nov 10, 2026
EPS / Forecast
-0.15 / -0.12
Revenue / Forecast
12.9M / 14.31M
EPS Revisions
Last 90 days

FAQ

What were TriSalus Life Sciences's earnings for the latest quarter?

The TriSalus Life Sciences EPS (TTM) is -0.49. TriSalus Life Sciences reported sales of 12.878, net income of -8.854, and EPS of -0.150 for the latest quarter.

What was TriSalus Life Sciences's net income for the latest quarter?

TriSalus Life Sciences's net income for the latest quarter was -8.854.

How did TriSalus Life Sciences's performance compare year-over-year in the latest quarter?

The company's revenue moved from 11.407 million USD in the previous quarter to 12.878 million USD in the latest quarter, and net income moved from -9.187 million USD to -8.854 million USD compared to the previous quarter.

What is TriSalus Life Sciences's net profit margin on a TTM basis?

TriSalus Life Sciences's trailing twelve months (TTM) net profit margin is -56.597%.

How does TriSalus Life Sciences's debt to equity ratio compare to industry standards?

TriSalus Life Sciences's total debt-to-equity ratio is 4,954.559%.

What is TriSalus Life Sciences's return on investment on a TTM basis?

TriSalus Life Sciences's trailing twelve months (TTM) return on investment (ROI) is 201.613%.

How has TriSalus Life Sciences's total revenue grown this year?

TriSalus Life Sciences's total revenue was 11.407 million USD in the previous quarter and 12.878 million USD in the latest quarter.

What is TriSalus Life Sciences's gross margin on a TTM basis?

TriSalus Life Sciences's trailing twelve months (TTM) gross margin is 86.456%.

What was TriSalus Life Sciences's revenue per share for the latest quarter?

TriSalus Life Sciences's revenue per share for the latest quarter was 3.713.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.